Bicycle Therapeutics (BCYC) Accumulated Depreciation (2018 - 2024)

Bicycle Therapeutics (BCYC) has 7 years of Accumulated Depreciation data on file, last reported at $16.6 million in Q2 2024.

• Quarterly Accumulated Depreciation rose 59.03% year-over-year to $16.6 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $16.6 million (up 59.03% YoY) and the FY2023 annual result came in at $13.4 million, up 70.33% from the prior year.
• Accumulated Depreciation improved to $16.6 million in Q2 2024, from $14.9 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $16.6 million in Q2 2024 to a low of $2.8 million in Q1 2020.
• A 5-year average of $7.3 million and a median of $5.1 million in 2022 frame the typical range for Accumulated Depreciation.
• Annual changes were most pronounced in 2022 — Accumulated Depreciation grew 15.09% — and 2023, when it soared 101.58%.
• Tracing BCYC's Accumulated Depreciation over 5 years: stood at $4.0 million in 2020, then advanced by 19.05% to $4.8 million in 2021, then surged by 63.81% to $7.9 million in 2022, then soared by 70.33% to $13.4 million in 2023, then gained by 23.99% to $16.6 million in 2024.
• The last three Accumulated Depreciation figures came in at $16.6 million (Q2 2024), $14.9 million (Q1 2024), and $13.4 million (Q4 2023), per Business Quant data.